ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1954

Association of CRP with BMI in Males and Females

Taik Kim1, Stephen J. Ganocy2, Maria Antonelli3, Douglas Einstadter4 and Stanley Ballou1, 1Rheumatology, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH, 3Department of Medicine/Division of Rheumatology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, OH, 4Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: body mass, C-reactive protein (CRP), laboratory tests and obesity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Epidemiology and Public Health Poster III: Rheumatic Disease Risk and Outcomes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

C-reactive Protein (CRP) is an inflammatory marker commonly used to help aid in diagnosis, assess disease activity or monitor response to therapy. It is well established that many factors alter the serum CRP level, excluding infectious, malignancy, or rheumatologic causes. Obesity has been demonstrated to be a risk factor that contributes to elevated CRP levels. There is evidence that adiposity influences CRP levels and not vice versa (1). The proposed mechanism is that human adipose tissue expresses and releases the pro-inflammatory cytokine interleukin-6, inducing low-grade systemic inflammation in individuals with excess body fat (2).

The widely accepted reference range of CRP in healthy individuals is <1.0 mg/dL. The objective of our study was to quantify the association between obesity and CRP in order to establish an upper reference limit CRP for a given body mass index (BMI) in a healthy adult population.

Methods:

The NHANES (National Health and Nutrition Examination Survey) data from 2000 to 2010 was analyzed. Age was limited to 21 years and above to represent the adult population. BMI was limited to ≤50 kg/m2 and CRP limited to ≤5 mg/dL to exclude extreme values. The total number of analyzed subjects was 37303.

Quantile regression analysis was used to determine the median (CRP50) and 95th percentile CRP (CRP95) at various BMI levels. CRP95 was accepted as the upper reference limit of CRP.

Subgroup analysis was done comparing a younger population (21 to 45 years old) and older population (50 years old and above) and all analyses were based on gender.

Results:

Both CRP50 and CRP95 increase with increase in BMI.

The slope estimate of CRP95 was higher in females compared to males (0.0761 vs 0.0455 (P<0.001), respectively).

From these results we derived a simple calculation to approximate the CRP95, or reference upper limit of CRP, for a given BMI:

Males: CRP ≤ 1.0 + ( BMI-25)/25

Females: CRP ≤ 1.0 + (BMI-25)/12.5

Subgroup analyses showed that the younger female subgroup had the highest increase in CRP95 (slope estimate=0.089) and the older male group showed almost no increase in CRP95 with increase in BMI (slope estimate=0.002).

Conclusion:

Serum CRP levels increase with BMI increase in adults, and are higher in females than males at all elevated levels of BMI. BMI seems to influence the 95th percentile CRP of younger females most and older males least.

We propose a practical calculation that can predict the upper reference limit of CRP for a given BMI.

Reference

1.       Int J Obes (Lond) 2011 Feb ; 35(2): 300–308

2.       JAMA 1999 Dec 8;282(22):2131-5


Disclosure: T. Kim, None; S. J. Ganocy, None; M. Antonelli, None; D. Einstadter, None; S. Ballou, None.

To cite this abstract in AMA style:

Kim T, Ganocy SJ, Antonelli M, Einstadter D, Ballou S. Association of CRP with BMI in Males and Females [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/association-of-crp-with-bmi-in-males-and-females/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-crp-with-bmi-in-males-and-females/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology